{
      "Rank": 429,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Autologous hematopoeitic stem cells and mesenchymal stem cells transduced with lentiviral vector carrying the FANCA gene ex vivo"
      ],
      "ArmGroupInterventionName": [
            "Genetic: Gene-modified autologous stem cells"
      ],
      "ArmGroupLabel": [
            "Gene-modified autologous stem cells"
      ],
      "ArmGroupType": [
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT03351868"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This is a Phase I/II clinical trial of gene therapy for treating Fanconi anemia using a self-inactivating lentiviral vector to functionally correct the defective gene. The objectives are to evaluate the safety and efficacy of the gene transfer clinical protocol."
      ],
      "BriefTitle": [
            "FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector"
      ],
      "CentralContactEMail": [
            "c@szgimi.org"
      ],
      "CentralContactName": [
            "Lung-Ji Chang, Ph.D"
      ],
      "CentralContactPhone": [
            "86-13671121909"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact"
      ],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "December 31, 2021"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Fanconi Anemia"
      ],
      "ConditionAncestorId": [
            "D000006402",
            "D000029502",
            "D000000741",
            "D000080984",
            "D000080983",
            "D000001855",
            "D000030342",
            "D000049914",
            "D000008659",
            "D000015499",
            "D000007674",
            "D000014570"
      ],
      "ConditionAncestorTerm": [
            "Hematologic Diseases",
            "Anemia, Hypoplastic, Congenital",
            "Anemia, Aplastic",
            "Congenital Bone Marrow Failure Syndromes",
            "Bone Marrow Failure Disorders",
            "Bone Marrow Diseases",
            "Genetic Diseases, Inborn",
            "DNA Repair-Deficiency Disorders",
            "Metabolic Diseases",
            "Renal Tubular Transport, Inborn Errors",
            "Kidney Diseases",
            "Urologic Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC15",
            "All",
            "BXS",
            "BC16",
            "BC18",
            "BC23",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Blood and Lymph Conditions",
            "All Conditions",
            "Urinary Tract, Sexual Organs, and Pregnancy Conditions",
            "Diseases and Abnormalities at or Before Birth",
            "Nutritional and Metabolic Diseases",
            "Symptoms and General Pathology",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Anemia",
            "Fanconi Anemia",
            "Fanconi Anemia",
            "Fanconi Anemia",
            "Fanconi Anemia",
            "Fanconi Anemia"
      ],
      "ConditionBrowseLeafId": [
            "M3222",
            "M7493",
            "M7494",
            "M15507",
            "M8642",
            "M22608",
            "M3223",
            "M12270",
            "M2241",
            "M2242",
            "M4286",
            "M22839",
            "M25284",
            "M10791",
            "M17303",
            "M9850",
            "M16471",
            "T2270",
            "T1464",
            "T2272"
      ],
      "ConditionBrowseLeafName": [
            "Anemia",
            "Fanconi Syndrome",
            "Fanconi Anemia",
            "Syndrome",
            "Hematologic Diseases",
            "Anemia, Hypoplastic, Congenital",
            "Anemia, Aplastic",
            "Pancytopenia",
            "Bone Marrow Failure Disorders",
            "Congenital Bone Marrow Failure Syndromes",
            "Bone Marrow Diseases",
            "Genetic Diseases, Inborn",
            "DNA Repair-Deficiency Disorders",
            "Metabolic Diseases",
            "Renal Tubular Transport, Inborn Errors",
            "Kidney Diseases",
            "Urologic Diseases",
            "Fanconi Anemia",
            "Congenital Aplastic Anemia",
            "Fanconi Syndrome"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "high",
            "high",
            "high"
      ],
      "ConditionMeshId": [
            "D000005198",
            "D000000740",
            "D000005199"
      ],
      "ConditionMeshTerm": [
            "Fanconi Syndrome",
            "Anemia",
            "Fanconi Anemia"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "N/A"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Fanconi anemia is a rare, inherited disease that is caused by a gene defect and that primarily affects an individual's bone marrow, resulting in decreased production of blood cells. The major problem for most patients is aplastic anemia, the blood counts for red blood cells, white blood cells, and platelets are low. In addition, some patients have physical defects usually involving the skeleton and kidneys. Fanconi anemia is typically diagnosed in childhood, and there is a high fatality rate. Hematopoietic stem cell transplantation (HSCT) is a common treatment for Fanconi anemia. However, there are many risks associated with HSCT including rejection of the transplanted cells and graft-versus-host disease.\n\nThe primary objectives are to evaluate the safety of the self-inactivating lentiviral vector, the ex vivo gene transfer clinical protocol and the efficacy of immune reconstitution in patients overcoming immune abnormalities present at the time of treatment, assessment of gene correction efficiency, and finally the long-term correction of Fanconi anemia associated disease symptoms."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nDiagnosis of Fanconi anemia FANCA type based on DNA sequencing and sensitivity test for chromosomal cleavage by mitomycin C or butylene oxide.\nNo cytogenetic abnormalities and the proportion of myelodysplastic abnormalities does not exceed 5% within 3 months prior to stem cell collection.\nAge: \u2265 4 years.\nKarnofsky: \u2265 70%.\nANC \u2265 5\u00d710^8/L; PLT \u2265 2\u00d710^10/L.\nHemoglobin \u2265 8g/dL.\n\nProper renal and hepatic functions (ULN denotes \"upper limit of normal range\") with\n\nserum creatinine \u2264 1.5\u00d7ULN;\nserum bilirubin \u2264 3\u00d7ULN;\nAST/ALT \u2264 5\u00d7ULN.\nPulmonary function is normal; DLCO > 50%.\nWritten, informed consent obtained prior to any study-specific procedures.\n\nExclusion Criteria:\n\nDiagnosis of active malignant disease or myelodysplastic syndrome.\nDiagnosis of myeloid leukemia.\nPregnant or lactating females.\nExistence of an available HLA-identical related donor.\nSubject infected with HBV (HBsAg positive), HIV (HIV antibody positive), HTLV (HTLV antibody positive), Treponema pallidum antibody positive or TB culture positive.\nPatients, in the opinion of investigators, may not be eligible or not able to comply with the study."
      ],
      "EnrollmentCount": [
            "10"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Gene-modified autologous stem cells"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Infusion for 5x10^6~1x10^7 per kilogram of body weight of gene-modified cells; or more infusions depending on the circumstances"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Gene-modified autologous stem cells"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Genetic"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Fanconi anemia",
            "Lentiviral vector",
            "FANCA",
            "Gene"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Recruiting"
      ],
      "LastUpdatePostDate": [
            "September 19, 2019"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "September 18, 2019"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "Shenzhen Geno-Immune Medical Institute"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Beijing",
            "Beijing",
            "Shenzhen"
      ],
      "LocationContactEMail": [
            "xsusan28@sina.com",
            "13780524314@163.com",
            "cutezjie@163.com",
            "c@szgimi.org"
      ],
      "LocationContactName": [
            "XiaoDong Shi, M.D./P.H.D",
            "Lixiao Shi, M.M.",
            "Jie Zheng, MD/PhD",
            "Lung-Ji Chang, PhD"
      ],
      "LocationContactPhone": [
            "+86-13911601076",
            "+86-18810963129",
            "+86-13683284467",
            "86-075586725195"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Contact",
            "Contact",
            "Contact"
      ],
      "LocationCountry": [
            "China",
            "China",
            "China"
      ],
      "LocationFacility": [
            "Capital Institute of Pediatrics affiliated Children's hospital",
            "Beijing Children's Hospital",
            "Shenzhen Geno-immune Medical Institute"
      ],
      "LocationState": [
            "Beijing",
            "Beijing",
            "Guangdong"
      ],
      "LocationStatus": [
            "Recruiting",
            "Recruiting",
            "Recruiting"
      ],
      "LocationZip": [
            "100020",
            "518000"
      ],
      "MaximumAge": [
            "20 Years"
      ],
      "MinimumAge": [
            "2 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Gene Transfer for Fanconi Anemia Using a Self-inactivating Lentiviral Vector"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "Shenzhen Geno-Immune Medical Institute"
      ],
      "OrgStudyId": [
            "GIMI-IRB-17021"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Shenzhen Geno-Immune Medical Institute",
            "Capital Institute of Pediatrics affiliated Children's hospital",
            "Beijing Children's Hospital"
      ],
      "OverallOfficialName": [
            "Lung-Ji Chang, Ph.D",
            "Xiao-Dong Shi, M.D./Ph. D",
            "Jie Zheng, M.D./Ph. D"
      ],
      "OverallOfficialRole": [
            "Principal Investigator",
            "Study Director",
            "Study Director"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Not Applicable"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 31, 2020"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Physiological parameter (measuring cytokine response, fever, symptoms)"
      ],
      "PrimaryOutcomeMeasure": [
            "Safety in patients using CTCAE version 4.0 standard to evaluate the level of adverse events"
      ],
      "PrimaryOutcomeTimeFrame": [
            "6 months"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "Shenzhen Geno-Immune Medical Institute"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "Lung-Ji Chang"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "President"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Principal Investigator"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Blood routine indexes will be obtained before and after treatment. Objective response, such as complete response (CR), partial response (PR), stable disease (SD), or progressive disease (PD) will be assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 criteria",
            "Quality of life will be measured using the Functional Assessment of Cancer Therapy-General (FACT-G) before and after treatment."
      ],
      "SecondaryOutcomeMeasure": [
            "Treatment responses",
            "Quality of life"
      ],
      "SecondaryOutcomeTimeFrame": [
            "1 year",
            "1 year"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "December 1, 2017"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "September 2019"
      ],
      "StdAge": [
            "Child",
            "Adult"
      ],
      "StudyFirstPostDate": [
            "November 24, 2017"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "November 20, 2017"
      ],
      "StudyFirstSubmitQCDate": [
            "November 20, 2017"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}